Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: A randomized, controlled, phase III trial-Reference-Cited by-同舟云学术

Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: A randomized, controlled, phase III trial

Published:2015-05 Issue:21 Volume:33 Page:2485-2492
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Cadorna-Carlos Josefina B.,Nolan Terry^ORCID,Borja-Tabora Charissa Fay,Santos Jaime,Montalban M. Cecilia,de Looze Ferdinandus J.,Eizenberg Peter,Hall Stephen,Dupuy Martin,Hutagalung Yanee,Pépin Stéphanie,Saville Melanie

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference26 articles.

1. The rationale for quadrivalent influenza vaccines;Ambrose;Hum Vaccin Immunother,2012

2. The need for quadrivalent vaccine against seasonal influenza;Belshe;Vaccine,2010

3. First quadrivalent flu vaccine approved;Traynor;Am J Health Syst Pharm,2012

4. Prevention and control of seasonal influenza with vaccines;Centers for Disease Control and Prevention;MMWR Recomm Rep,2013

5. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine;Reed;Vaccine,2012

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase I Clinical Study of the Subunit Betulin-Adjuvanted Tetravalent Candidate Influenza Vaccine TetraFluBet;Vaccines;2024-09-05

2. Lot-to-lot consistency, immunogenicity and safety of a quadrivalent split virion inactivated influenza vaccine in healthy population aged 9–59 years: A randomized, double-blind, controlled, phase IV clinical trial;Vaccine;2024-08

3. Lot-to-Lot Consistency, Immunogenicity and Safety of a Quadrivalent Influenza Vaccine (Split Virion), Inactivated (IIV4) in Healthy Population Aged 9-59 Years: A Randomized, Double-Blind, Controlled, Phase Ⅳ Clinical Trial;2024

4. Influvac Tetra: clinical experience on safety, efficacy, and immunogenicity;Expert Review of Vaccines;2023-12-15

5. Sex differences in adverse events following seasonal influenza vaccines: a meta-analysis of randomised controlled trials;Journal of Epidemiology and Community Health;2023-09-21